Home
»
Press Room
»
Biobanks Market Size To Reach $160.54 Billion By 2033

Biobanks Market Size To Reach $160.54 Billion By 2033

December 2025 | Report Format: Electronic (PDF)

Biobanks Market Growth & Trends

The global biobanks market size is expected to reach USD 160.54 billion by 2033, registering a CAGR of 8.11% from 2026 to 2033, according to a new report by Grand View Research, Inc. Biobanks continue to evolve with the introduction of new technologies, such as NGS, and increased focus on genomic medicine. The availability of several types of biospecimens to cater to multiple domains including drug discovery, diagnostics, and others has accelerated the diversification of biorepositories, thereby driving the market. The quality of biospecimens can significantly influence disease testing as well as preclinical and clinical research. Regulatory agencies have played a vital role in spurring the adoption of biobanking services by establishing guidelines for the effective management of samples.

For instance, the U.S. Centers for Disease Control and Prevention (CDC) released guidelines to minimize human hazards while handling COVID-19 samples. This serves as a model for other biorepositories. Furthermore, as the number of research studies and clinical trials related to COVID-19 is increasing, the demand for high-quality biospecimens is expected to significantly increase in the near future, leading to market growth. In addition, population-based cohort studies are facilitated by biorepositories to estimate the actual seroprevalence. Health Catalyst, Inc., through its Touchstone platform, provides national data related to COVID-19 insights. Such factors are anticipated to contribute to the revenue flow in this space.

The ‘BioResource’ was created in October 2021 by RareCan, a Hexham-based healthcare start-up dedicated to improving studies into the uncommon forms of cancer. BioResource will retain samples taken after surgery from cancer patients and make them accessible to researchers across the globe who can use them to cure, prevent, and identify the disease. In December 2021, Newcastle University introduced a new collection of human blood samples and donated human tissue, which could transform efforts to cure rare cancers. The U.K. Biobank has announced that fresh data from a study measuring the range of circulatory metabolomics biomarkers has been added to its database. Nightingale Health, a Finnish business specializing in blood biomarker technologies, conducted the study with 120000 participants.

North America dominated the market with its wide network of centers for biosample storage in the U.S. Moreover, a high number of COVID-19 cases in the U.S. and increased R&D programs have resulted in the establishment of new biorepositories, thereby driving revenue in North America. In Asia Pacific, the market is anticipated to register the fastest growth owing to the ever-expanding pharmaceuticals and clinical research domain across Asian countries. The key players are engaged in expanding their global reach by partnering with global distributors, mergers, and acquisitions of other players, and entering a strategic alliance with research communities.

key Request a free sample copy or view report summary: Biobanks Market Report

Biobanks Market Report Highlights

The biobanks market has witnessed significant innovation, from traditional methods of sample storage to the utilization of cutting-edge technologies for data management, analytics, and automation
In the biobanks industry, regional expansion involves biobanking entities strategically broadening their activities beyond current geographic boundaries.
The services segment dominated the biobanks market, accounting for the largest revenue share in 2025, and is anticipated to grow at the fastest CAGR during the forecast period
The human tissues segment dominated the biobanks industry, capturing the largest revenue share of 36.26% in 2025. This is due to the presence of many biobanks with facilities to store tissues, the easy availability of tissues
The physical/real biobanks segment dominated the market in 2025, with the largest revenue share. These biobanks have a well-established network, thereby holding a high revenue share.
In 2025, the therapeutics application segment dominated the biobanks industry, with the largest revenue share of 36.21%.
Europe accounted for the largest revenue share of 39.26% in 2025, owing to the continuous investment in the collection, establishment, and processing of large-scale datasets

Biobank Market Segmentation

Grand View Research has segmented the global biobanks market report based on product & service, biospecimen type, biobank type, application, and region:

Biobanks Product & Services Outlook (Revenue, USD Million, 2021 - 2033)

Product
- Biobanking Equipment
  - Temperature Control Systems
    - Freezers & Refrigerators
    - Cryogenic Storage Systems
    - Thawing Equipment
  - Incubators & Centrifuges
  - Alarms & Monitoring Systems
  - Accessories & Other Equipment
- Biobanking Consumables
- Laboratory Information Management Systems
Services
- Biobanking & Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Services